Pradaxa

A prescription blood thinner (generically referred to as dabigatran), Pradaxa was approved by the FDA in 2010 to help patients prevent strokes and other complications caused by blood clots. When compared against its main competitor, warfarin, Pradaxa was deemed superior in its ability to reduce the risk of strokes more effectively. In addition, it has fewer restrictions than warfarin, and is easier to administer. Part of the drug class called “direct thrombin inhibitors,” Pradaxa reduces the action of the clotting protein thrombin.

The side effects of this anticoagulant, however, range from deceptively simple stomach pain and nausea to uncontrollable bleeding, heart attack, liver failure, and death. An FDA safety announcement from 2014 stated that Pradaxa was associated with an increased risk of major gastrointestinal bleeding, as well as a similar risk of heart attack and symptoms of heart disease to its market competitor warfarin. An independent Cleveland Clinic study in 2012, however, found that Pradaxa in fact has a 33% higher risk of heart disease and heart attack than warfarin.

If you or a loved one has experienced side effects from taking Pradaxa such as hemorrhaging heart attack, symptoms of liver failure, or unusual bruising please call The Law Offices of George Salinas today. It is our goal to help you get the treatment, care, and compensation that you deserve. At The Law Offices of George Salinas, we offer free consultation and a thorough analysis of your case. We’ll fight for you: let us ask the tough questions and demand honest answers. Call (210) 225.0909 today.